Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Pathology

• Publication date

  2016-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/bpa.12289PMID 26193084PMCID PMC4720581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroanatomy and Pathology of Sporadic Alzheimer's Disease Prologue

  2015cited by this paper
• PART, a distinct tauopathy, different from classical sporadic Alzheimer disease

  2015cited by this paper
• PART is part of Alzheimer disease

  2015cited by this paper
• Neuroanatomy and pathology of sporadic Alzheimer's disease.

  2015influential reference
• Mechanisms of protein seeding in neurodegenerative diseases.

  2013influential reference
• The serotonergic system in ageing and Alzheimer's disease.

  2012cited by this paper
• Serotonergic modulation of Neural activities in the entorhinal cortex.

  2012cited by this paper
• Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.

  2012cited by this paper
• Sporadic human prion diseases: molecular insights and diagnosis.

  2012cited by this paper
• Tauons and Prions: Infamous Cousins?

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders

  2011influential reference
• Opportunities and challenges in developing Alzheimer disease therapeutics

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Prions and protein‐folding diseases

  2011cited by this paper
• TDP-43 in aging and Alzheimer's disease - a review.

  2011cited by this paper
• Tau in Alzheimer disease and related tauopathies.

  2010cited by this paper
• Tau, prions and Aβ: the triad of neurodegeneration

  2010influential reference
• The propagation of prion-like protein inclusions in neurodegenerative diseases.

  2010influential reference
• Targeting Tau Protein in Alzheimer’s Disease

  2010cited by this paper
• Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

  2010cited by this paper
• Molecular pathology of human prion disease

  2010cited by this paper
• Mechanisms of tau-induced neurodegeneration

  2009cited by this paper
• Classification and basic pathology of Alzheimer disease

  2009influential reference
• Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.

  2009cited by this paper
• Does Alzheimer's disease begin in the brainstem?

  2009influential reference
• Paraventricular thalamic nucleus: Subcortical connections and innervation by serotonin, orexin, and corticotropin‐releasing hormone in macaque monkeys

  2009cited by this paper
• Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

  2009cited by this paper
• The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?

  2009cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Surgical anatomy of the pedunculopontine and peripeduncular nuclei

  2008cited by this paper
• Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

  2008cited by this paper
• Neuroanatomy and pathology of sporadic Parkinson's disease.

  2008cited by this paper
• Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets

  2008cited by this paper
• Dementia of the Alzheimer type.

  2008cited by this paper
• Role of axonal transport in neurodegenerative diseases.

  2008cited by this paper
• Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.

  2008cited by this paper
• Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

  2007cited by this paper
• Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.

  2007cited by this paper
• A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases.

  2007cited by this paper
• The dorsal raphe nucleus--from silver stainings to a role in depression.

  2007cited by this paper
• Tau protein, the paired helical filament and Alzheimer's disease

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006influential reference
• Axonal transport and Alzheimer's disease.

  2006cited by this paper
• Alzheimer's disease

  2006cited by this paper
• Alzheimer 100 – highlights in the history of Alzheimer research

  2006cited by this paper
• Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

  2005cited by this paper
• Alzheimer's disease affects limbic nuclei of the thalamus

  2004cited by this paper
• Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum

  2004cited by this paper
• A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004influential reference
• Infiltration of the brain by pathogens causes Alzheimer's disease.

  2004cited by this paper
• The human raphe nuclei and the serotonergic system.

  2003cited by this paper
• Involvement of precerebellar nuclei in multiple system atrophy

  2003influential reference
• The intralaminar nuclei assigned to the medial pain system and other components of this system are early and progressively affected by the Alzheimer's disease-related cytoskeletal pathology.

  2002cited by this paper
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002influential reference
• Axonal transport, tau protein, and neurodegeneration in Alzheimer’s disease

  2002cited by this paper
• The selective vulnerability of brainstem nuclei to Alzheimer's disease

  2001cited by this paper
• The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology

  2001cited by this paper
• Gender and age modify the association between APOE and AD-related neuropathology

  2001cited by this paper
• The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease

  2000cited by this paper
• Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert

  2000cited by this paper
• The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei

  2000influential reference
• Projections of the parabrachial nucleus in the old world monkey.

  2000cited by this paper
• Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.

  1999cited by this paper
• Severe pathological changes of parabrachial nucleus in Alzheimer's disease

  1998cited by this paper
• Neuropathological criteria for the diagnosis of Alzheimer's disease.

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.

  1997cited by this paper
• Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.

  1997influential reference
• Prevalence, incidence and duration of Braak's stages in the general population: can we know?

  1997cited by this paper
• Diagnosis and staging of Alzheimer disease.

  1997cited by this paper
• Functional anatomy of human hippocampal formation and related structures.

  1996cited by this paper
• Topical Review: Functional Anatomy of Human Hippocampal Formation and Related Structures

  1996cited by this paper
• On the structure of microtubules, tau, and paired helical filaments.

  1995cited by this paper
• Lesions in the Pulvinar in Patients with Alzheimer's Disease

  1994cited by this paper
• The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.

  1993cited by this paper
• Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

  1993cited by this paper
• Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

  1993cited by this paper
• Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: A light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity

  1992cited by this paper
• The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases.

  1992cited by this paper
• Serotoninergic innervation of the thalamus in the primate: An immunohistochemical study

  1991cited by this paper
• Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus

  1991cited by this paper
• Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains.

  1991cited by this paper
• Pathological alterations in the amygdala in Alzheimer's disease.

  1990cited by this paper
• Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex

  1987influential reference
• The entorhinal cortex of the monkey: III. Subcortical afferents

  1987influential reference
• Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease.

  1987cited by this paper
• Hypothalamic pathology in Alzheimer's disease.

  1987cited by this paper
• The afferent connections of the substantia innominata in the monkey, Macaca fascicularis

  1985cited by this paper
• Connections of midbrain periaqueductal gray in the monkey. I. Ascending efferent projections.

  1983cited by this paper
• Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining.

  1983cited by this paper
• Connections of midbrain periaqueductal gray in the monkey. II. Descending efferent projections.

  1983cited by this paper
• The morphology and connections of the posterior hypothalamus in the cynomolgus monkey (Macaca fascicularis). II. Efferent connections

  1982cited by this paper
• Subcortical afferents to the hippocampal formation in the monkey

  1980cited by this paper
• Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta).

  1980cited by this paper
• Subcortical afferent connections of the amygdala in the monkey

  1980cited by this paper
• Midbrain, diencephalic and cortical relationships of the basal nucleus of meynert and associated structures in primates

  1976cited by this paper

• Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus.

  2026cites this paper
• Membrane Proteome Remodeling in Female APP Mice Following Muscarinic Acetylcholine Receptor M1 Modulation Revealed by Peptidisc Enabled DIA-MS

  2026cites this paper
• Acupuncture-induced changes in locus coeruleus connectivity and memory improvement in patients with amnestic cognitive impairment

  2026cites this paper
• Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease

  2025cites this paper
• Locus coeruleus‐entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein

  2025cites this paper
• Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration.

  2025cites this paper
• Differences in LC integrity and fMRI activations in healthy aging and MCI associated with successful memory encoding

  2025cites this paper
• The rhythm of decline: Circadian disruption in neurodegeneration

  2025cites this paper
• Associations of Chronic Insomnia, Longitudinal Cognitive Outcomes, Amyloid-PET, and White Matter Changes in Cognitively Normal Older Adults.

  2025cites this paper
• The impact of polygenic risk for alzheimer’s disease on neurotransmitter-related grey matter atrophy in the alzheimer continuum

  2025cites this paper
• Sequence and trajectory of early Alzheimer’s disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits

  2025cites this paper
• Lower locus coeruleus integrity is associated with diminished practice effects in clinically unimpaired older individuals.

  2025cites this paper
• Neurotrophic factor alpha 1 gene therapy in Alzheimer’s disease: scope and advancements

  2025cites this paper
• Pathways underlying selective neuronal vulnerability in Alzheimer's disease: Contrasting the vulnerable locus coeruleus to the resilient substantia nigra

  2025cites this paper
• Locus coeruleus tau validates and informs high-resolution MRI in aging and at earliest Alzheimer’s pathology stages

  2025cites this paper
• Changes in neurotransmitter-related functional connectivity along the Alzheimer’s disease continuum

  2025cites this paper
• ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer's disease.

  2025cites this paper
• Importance of Gut Microbiota Dysbiosis and Circadian Disruption–Associated Biomarkers in Emergence of Alzheimer’s Disease

  2025cites this paper
• Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy

  2025cites this paper
• Examining resilience to Alzheimer's disease through the lens of monoaminergic neuromodulator systems.

  2024cites this paper
• Auditory brainstem responses as a biomarker for cognition

  2024cites this paper
• Locus coeruleus MRI contrast, cerebral perfusion, and plasma Alzheimer's disease biomarkers in older adults.

  2024cites this paper
• Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease

  2024cites this paper
• From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment

  2024cites this paper
• Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus

  2024cites this paper
• Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition

  2024cites this paper
• Deep brain stimulation for Alzheimer’s disease – current status and next steps

  2024cites this paper
• Longitudinal evolution and plasma biomarkers for excessive daytime sleepiness in Parkinson's disease.

  2024cites this paper
• Is Alzheimer disease a disease?

  2024cites this paper
• Aging and sex are associated with multiple sleep latency test findings and their relationship with self-reported sleepiness

  2024cites this paper
• Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment

  2023cites this paper
• Sex and Sleep Disruption as Contributing Factors in Alzheimer’s Disease

  2023cites this paper
• Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin.

  2023cites this paper
• Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer’s disease

  2023cites this paper
• Declining locus coeruleus-dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer's disease.

  2023cites this paper
• The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance

  2023cites this paper
• Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice

  2023cites this paper
• Poorer aging trajectories are associated with elevated serotonin synthesis capacity

  2023cites this paper
• Noradrenergic neuromodulation in ageing and disease.

  2023cites this paper
• Depressive symptoms associated with brain morphometry in Mild Cognitive Impairment stage due to Alzheimer’s and Parkinson’s disease

  2023cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy

  2023cites this paper
• An updated overview of recent and ongoing deep brain stimulation (DBS) trials in patients with dementia: a systematic review

  2023cites this paper
• Brain amyloid-β deposition associated functional connectivity changes of ultra-large structural scale in mild cognitive impairment

  2023cites this paper
• Rise and fall of peroxisomes during Alzheimer´s disease: a pilot study in human brains

  2023cites this paper
• Altered structural covariance of locus coeruleus in individuals with significant memory concern and patients with mild cognitive impairment.

  2023cites this paper
• Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AβPP/PS1 AD Mice and Their Wild-Type Littermates

  2023cites this paper
• Hippocampal Noradrenaline Is a Positive Regulator of Spatial Working Memory and Neurogenesis in the Rat

  2023cites this paper
• Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART

  2023cites this paper
• Deep Brain Stimulation of Fornix for Memory Improvement in Alzheimer's disease: A Critical Review.

  2022cites this paper
• Alzheimer’s disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR‐edited human neuronal cells

  2022cites this paper
• High resolution and high sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study.

  2022cites this paper
• Acetylcholine and noradrenaline differentially regulate hippocampus-dependent spatial learning and memory

  2022cites this paper
• Association between lower body temperature and increased tau pathology in cognitively normal older adults

  2022cites this paper
• State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities.

  2022cites this paper
• Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases.

  2022cites this paper
• Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus–pericoerulear complex by three-dimensional imaging

  2022cites this paper
• Research advances in the study of sleep disorders, circadian rhythm disturbances and Alzheimer’s disease

  2022cites this paper
• The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease

  2022cites this paper
• Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

  2022cites this paper
• ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease

  2021cites this paper
• The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer’s disease

  2021cites this paper
• Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches

  2021cites this paper
• Brainstem substructures and cognition in prodromal Alzheimer’s disease

  2021cites this paper
• The 'a, b, c's of pretangle tau and their relation to aging and the risk of Alzheimer's Disease.

  2021cites this paper
• Deepen into sleep and wake patterns across Alzheimer's disease phenotypes

  2021cites this paper
• Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses

  2021cites this paper
• The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review

  2021cites this paper
• Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer’s disease

  2021cites this paper
• Transcutaneous vagus nerve stimulation (tVNS) as a potential therapeutic application for neurodegenerative disorders - A focus on dysautonomia in Parkinson's disease.

  2021cites this paper
• Synaptic tau: A pathological or physiological phenomenon?

  2021cites this paper
• Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer's disease.

  2021cites this paper
• MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities

  2021cites this paper
• Association between lower body temperature and increased tau pathology in cognitively normal older adults

  2021cites this paper
• Neuropathology of Alzheimer’s Disease

  2021cites this paper
• Is There Any Evidence of Monocytes Involvement in Alzheimer’s Disease? A Pilot Study on Human Postmortem Brain

  2021cites this paper
• Novelty‐like activation of locus coeruleus protects against deleterious human pretangle tau effects while stress‐inducing activation worsens its effects

  2021cites this paper
• Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy.

  2020cites this paper
• Automated Segmentation of the Locus Coeruleus from Neuromelanin-Sensitive 3T MRI Using Deep Convolutional Neural Networks

  2020cites this paper
• Is milk and dairy intake a preventive factor for elderly cognition (dementia and Alzheimer's)? A quality review of cohort surveys.

  2020cites this paper
• Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510

  2020cites this paper
• Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer’s Disease

  2020cites this paper
• Running head: LOWER LOCUS COERULEUS INTEGRITY IN ALZHEIMER’S 1 Lower MR-indexed locus coeruleus integrity in autosomal-dominant Alzheimer’s disease is related to cortical tau burden and memory deficits

  2020cites this paper
• Irisin treatment lowers levels of phosphorylated tau in the hippocampus of pre‐symptomatic female but not male htau mice

  2020cites this paper
• Lower MR-indexed locus coeruleus integrity in autosomal-dominant Alzheimer's disease is related to cortical tau burden and memory deficits

  2020cites this paper
• Biomarkers for Alzheimer’s Disease Early Diagnosis

  2020cites this paper
• Novel MRI Techniques Identifying Vascular Leak and Paravascular Flow Reduction in Early Alzheimer Disease

  2020cites this paper
• Associations of [18F]-APN-1607 Tau PET Binding in the Brain of Alzheimer’s Disease Patients With Cognition and Glucose Metabolism

  2020cites this paper
• Calbindin-D28K, parvalbumin, and calretinin in young and aged human locus coeruleus.

  2020cites this paper
• The Sleep Side of Aging and Alzheimer's Disease.

  2020cites this paper
• Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions

  2020cites this paper
• Relevance of biomarkers across different neurodegenerative

  2020cites this paper
• Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge—A New Hypothesis With Potential Implications for Neurodegenerative Diseases

  2020cites this paper
• Circadian and Sleep Dysfunction in Alzheimer's Disease.

  2020cites this paper
• Anatomy and function of the fornix in the context of its potential as a therapeutic target

  2020cites this paper
• An experimental model of Braak’s pretangle proposal for the origin of Alzheimer’s disease: the role of locus coeruleus in early symptom development

  2019cites this paper
• Mitigating Alzheimer's Disease by Natural Polyphenols : A Review.

  2019cites this paper
• Sleep and Attention in Alzheimer’s Disease

  2019cites this paper
• 1 Mitigating Alzheimer ’ s Disease with Natural Polyphenols : a Review

  2019cites this paper
• OP-BRAI190197 2558..2571

  2019cites this paper